Journal article
Insulin Signaling and Heart Failure
Circulation research, Vol.118(7), pp.1151-1169
04/01/2016
DOI: 10.1161/CIRCRESAHA.116.306206
PMCID: PMC4833475
PMID: 27034277
Abstract
Heart failure is associated with generalized insulin resistance. Moreover, insulin-resistant states such as type 2 diabetes mellitus and obesity increases the risk of heart failure even after adjusting for traditional risk factors. Insulin resistance or type 2 diabetes mellitus alters the systemic and neurohumoral milieu, leading to changes in metabolism and signaling pathways in the heart that may contribute to myocardial dysfunction. In addition, changes in insulin signaling within cardiomyocytes develop in the failing heart. The changes range from activation of proximal insulin signaling pathways that may contribute to adverse left ventricular remodeling and mitochondrial dysfunction to repression of distal elements of insulin signaling pathways such as forkhead box O transcriptional signaling or glucose transport, which may also impair cardiac metabolism, structure, and function. This article will review the complexities of insulin signaling within the myocardium and ways in which these pathways are altered in heart failure or in conditions associated with generalized insulin resistance. The implications of these changes for therapeutic approaches to treating or preventing heart failure will be discussed.
Details
- Title: Subtitle
- Insulin Signaling and Heart Failure
- Creators
- Christian Riehle - From the Division of Endocrinology and Metabolism, Fraternal Order of Eagles Diabetes Research Center, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa CityE Dale Abel - From the Division of Endocrinology and Metabolism, Fraternal Order of Eagles Diabetes Research Center, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City. DRCadmin@uiowa.edu
- Resource Type
- Journal article
- Publication Details
- Circulation research, Vol.118(7), pp.1151-1169
- Publisher
- United States
- DOI
- 10.1161/CIRCRESAHA.116.306206
- PMID
- 27034277
- PMCID
- PMC4833475
- ISSN
- 0009-7330
- eISSN
- 1524-4571
- Grant note
- R01 HL73167 / NHLBI NIH HHS R01 HL070070 / NHLBI NIH HHS R01 HL108379 / NHLBI NIH HHS R01 DK092065 / NIDDK NIH HHS U01 HL087947 / NHLBI NIH HHS R21 DK073590 / NIDDK NIH HHS R01HL10837 / NHLBI NIH HHS R01 HL112413 / NHLBI NIH HHS R01 HL12357 / NHLBI NIH HHS R01DK092065 / NIDDK NIH HHS R01 HL073167 / NHLBI NIH HHS R21DK073590 / NIDDK NIH HHS R01 HL127764 / NHLBI NIH HHS
- Language
- English
- Date published
- 04/01/2016
- Academic Unit
- Roy J. Carver Department of Biomedical Engineering; Fraternal Order of Eagles Diabetes Research Center; Biochemistry and Molecular Biology; Endocrinology and Metabolism; Internal Medicine
- Record Identifier
- 9984025263602771
Metrics
23 Record Views